New eye scans could revolutionize how we see retinal disease

NCT ID NCT05355415

Recruiting now Knowledge-focused Sponsor: Food and Drug Administration (FDA) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study uses special cameras to take ultra-detailed pictures of the back of the eye in people with retinal diseases like macular degeneration and retinitis pigmentosa. Researchers aim to develop new ways to diagnose and track these conditions by measuring cell density and function. The study will enroll 100 adults and involves no treatment—only imaging.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better diagnostic tools and biomarkers for tracking retinal diseases, helping doctors detect changes earlier and monitor treatments more accurately.
What could go wrong: This is an observational imaging study, not a treatment trial. It is small (100 participants) and early-stage, so the findings may not apply to all patients or lead directly to clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

Food and Drug Administration
RECRUITING

Silver Spring, Maryland, 20993, United States
NIH Clinical Center
RECRUITING

Bethesda, Maryland, 20810, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.